Form 4: Dayforce Executive Jeffrey Jacobs Reports Stock Transactions
SEC Form 4 Filing
Jeffrey Jacobs, Head of Accounting & Financial Reporting at Dayforce, Inc., reports the sale and acquisition of company stock and derivative securities.
Summary
- Jeffrey Jacobs, Head of Accounting & Financial Reporting at Dayforce, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On October 15, 2024, Jacobs sold 143 shares of common stock at $63.37 per share.
- On the same day, Jacobs acquired 500 shares of common stock at $17.58 per share and then sold 500 shares at $63.37 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Jacobs directly owns 34,074 shares of Dayforce, Inc.
- Jacobs also holds options to buy shares at various prices and vesting schedules, as well as performance units that will convert into common stock based on company performance.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy, and the executive maintains a significant stake in the company.
Positives
- The executive's transactions are being conducted under a pre-arranged 10b5-1 trading plan, which suggests the transactions are not based on insider information.
- The executive still holds a significant number of shares and derivative securities, indicating continued alignment with the company's success.
Negatives
- The sale of shares by an executive could be perceived negatively by some investors, although the pre-planned nature of the transactions mitigates this concern.
Risks
- Fluctuations in Dayforce, Inc.'s stock price could impact the value of the executive's holdings and the potential value of the performance units.
- The actual number of shares issued from performance units depends on the company's performance against metrics under the 2024 Management Incentive Plan, which introduces uncertainty.
Future Outlook
The number of shares ultimately vesting from the performance units is contingent on the company's performance against metrics under the 2024 Management Incentive Plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without raising concerns about insider trading.
Comparison to Industry Standards
- Executive compensation packages, including stock options and performance-based units, are standard practice among publicly traded companies like Dayforce, Inc.
- Companies such as Workday, Oracle, and SAP also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and performance metrics associated with these equity grants are typically benchmarked against industry peers to ensure competitiveness and effectiveness in incentivizing performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the potential dilution from the vesting of restricted stock units and performance units.
- The transactions are unlikely to significantly impact employees, customers, suppliers, or creditors.
Next Steps
- Monitor future filings by the reporting person to track changes in beneficial ownership.
- Assess company performance against the metrics defined in the 2024 Management Incentive Plan to estimate the potential payout of performance units.
Key Dates
| Date | Description |
|---|---|
| February 22, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| February 24, 2022 | Date of grant for 1,412 restricted stock units (RSUs) vesting on February 24, 2025 |
| February 28, 2023 | Date of grant for 5,485 restricted stock units (RSUs) vesting on February 28, 2025 and February 28, 2026 |
| June 18, 2024 | Date the Reporting Person modified the Rule 10b5-1 trading plan |
| March 1, 2024 | Date of grant for 14,652 restricted stock units (RSUs) vesting on March 1, 2025, March 1, 2026, and March 1, 2027 |
| October 15, 2024 | Date of the reported transactions: sale of 143 shares and acquisition/sale of 500 shares |
| October 17, 2024 | Date of the Form 4 filing |
| December 31, 2024 | Fiscal year end date for determining performance metrics under the 2024 MIP |
| February 24, 2025 | Vesting date for 1,412 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| February 28, 2025 | Vesting date for 2,742 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| March 1, 2025 | Vesting date for 4,884 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| February 28, 2026 | Vesting date for 2,743 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| March 1, 2026 | Vesting date for 4,884 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| March 1, 2027 | Vesting date for 4,884 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.